肠道微生物群的饮食指数与女性人口中便秘之间的关联:一个横截面研究
Wangfeng Lu1, Gang Feng2, Lei Liu1
1Department of Gastrointestinal Surgery, Shangluo Central Hospital, Shangluo, Shanxi, China.
Frontiers in nutrition
|April 16, 2025
概括
较高的肠道微生物群 (DI-GM) 饮食指数得分与成年女性便秘发病率较低有关. 这表明饮食结构影响便秘,使饮食干预成为关键的治疗策略.
科学领域:
- 肠道微生物群研究研究
- 营养科学 营养科学
- 胃肠病学 胃肠病学
背景情况:
- 便秘是一种普遍的胃肠道问题,影响了许多成年女性.
- 饮食模式显著影响肠道微生物群的组成和功能.
- 了解肠道微生物群在便秘中的作用对于开发有效干预措施至关重要.
研究的目的:
- 为了研究肠道微生物群 (DI-GM) 的饮食指数与美国成年女性的便秘之间的联系.
- 为了确定DI-GM得分是否可以预测便秘风险.
- 探索饮食结构对肠道健康和便秘的影响.
主要方法:
- 这是一项采用2005-2010年美国国家健康调查 (NHANES) 数据的横截面研究.
- 采用多变量逻辑回归模型来分析DI-GM与便秘之间的关联.
- 缺少的共同变量值使用多重归算技术进行了归算.
主要成果:
- 在DI-GM得分和便秘之间观察到显著的负相关性 (OR 0.92;95% CI 0.87-0.96;p=0.001).
- 有益的肠道微生物群评分也显示出与便秘有显著的负相关性 (OR 0.89;95% CI 0.84-0.95;p=0.001).
- 亚组分析证实了DI-GM和便秘关系的稳定性.
结论:
- DI-GM得分与成年女性便秘发病率有负相关性.
- 饮食结构在控制女性便秘方面起着至关重要的作用.
- 饮食干预是综合性便秘管理的一个重要策略.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
246
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
246
Drugs for Treatment of Constipation-Predominant IBS
111
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
111
Irritable Bowel Syndrome I: Introduction
207
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
207
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
98
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
98
Chronic Bowel Disorders: Introduction
325
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
325
Assessment of the Gastrointestinal System I: Subjective Data
127
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
127


